|
2025
|
Invention
|
Combination therapy of a type ii anti-cd20 antibody with a selective bcl-2 inhibitor.
The presen... |
|
|
Invention
|
Processes for producing compositions with improved safety profile having lipase activity and comp... |
|
2024
|
Invention
|
Elagolix sodium compositions and processes.
The present invention relates to compositions of ela... |
|
|
Invention
|
Methods for treating hcv.
The present invention features interferon-free therapies for the treat... |
|
|
Invention
|
Anti-papp-a antibodies and methods of use thereof.
Provided herein are anti-PAPP-A antibodies. A... |
|
|
Invention
|
Anti-sez6 antibody drug conjugates.
The present disclosure provides SEZ6 antibody drug conjugate... |
|
|
Invention
|
Methods of administering elagolix.
The present disclosure relates to the use of GnRH receptor an... |
|
|
Invention
|
Anti-hemojuvelin (hjv) antibodies for treating myelofibrosis.
Aspects of the application provide... |
|
|
Invention
|
Single-chain trail-receptor agonist proteins.
Provided herein are specific TRAIL receptor agonis... |
|
|
Invention
|
Clostridium botulinum neurotoxin serotype a compositions.
The present disclosure relates to Clos... |
|
|
Invention
|
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases.
Disclo... |
|
|
Invention
|
Methods of treatment of diseases in which il-13 activity is detrimental using anti-il-13 antibodi... |
|
|
Invention
|
Methods of treating human immunodeficiency virus (hiv) disease.
The invention described herein r... |
|
|
Invention
|
Methods of treating human immunodeficiency virus (hiv) disease. The invention described herein re... |
|
|
Invention
|
Upadacitinib for treating alopecia areata. The present disclosure is directed to methods for trea... |
|
|
Invention
|
Methods of treating alopecia araeta.
The present disclosure is directed to methods for treating ... |
|
|
Invention
|
Bromodomain inhibitors.
The present invention provides for compounds of formula (I)
The presen... |
|
|
Invention
|
Container cap |
|
|
Invention
|
Anti-human cd33 bet degrader antibody-drug conjugates. The present disclosure provides anti-human... |
|
|
Invention
|
Methods of treatment using anti-c-met antibody drug conjugates. The present application pertains ... |
|
|
Invention
|
Methods of treating vitiligo with upadacitinib.
The present disclosure is directed to methods fo... |
|
|
Invention
|
Methods of treating vitiligo with upadacitinib. The present disclosure is directed to methods for... |
|
|
Invention
|
Systems and methods for generating longitudinal data profiles from multiple data sources.
A comp... |
|
|
Invention
|
Anti-amyloid beta antibodies and methods of using the same.
The present inventive concept is rel... |
|
|
Invention
|
Sealing arrangement for syringe.
A syringe containing a high water content product and for use i... |
|
|
Invention
|
Protein tyrosine phosphatase inhibitors and methods of use thereof.
Provided herein are compound... |
|
|
G/S
|
Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musc... |
|
|
Invention
|
Thiazolo[5,4-b]pyridine malt-1 inhibitors.
The present disclosure provides for compounds of the ... |
|
|
G/S
|
dietitian services in connection with clinical trials |
|
|
Invention
|
Enzyme compositions with reduced viral and microbial contamination.
The present invention pertai... |
|
|
Invention
|
1,3,4,7-tetrahydro-2h-pyrrolo[3',2':5,6]pyrido[2,3-b][1,4]oxazepine bcl-2 inhibitors.
The presen... |
|
|
Invention
|
Macrocyclic mcl-1 inhibitors and methods of use.
The present disclosure provides for compounds o... |
|
|
Invention
|
Selective reduction of antibodies.
The present disclosure provides methods for selectively reduc... |
|
|
Invention
|
Process for manufacturing pibrentasvir active drug substance.
The present invention relates to c... |
|
|
Invention
|
Treatment of major depressive disorder.
The present disclosure provides methods for the treatmen... |
|
|
Invention
|
Wearable automatic injection device for controlled administration of therapeutic agents.
Exempla... |
|
2023
|
G/S
|
Eye drops |
|
|
G/S
|
Ophthalmic preparations, namely, lubricant eye drops |
|
|
G/S
|
providing information about medical clinical trials, namely, information in the field of improvin... |
|
|
Invention
|
Carrying pack for medical device |
|
|
G/S
|
Providing medical information in the field of improving diversity and inclusion in clinical resea... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of glaucoma |
|
|
G/S
|
Providing a website featuring information in the field of the diagnosis and pharmaceutical treatm... |
|
2022
|
Invention
|
Methods for treating anemia of kidney disease.
Aspects of the application provide hemojuvelin an... |
|
|
G/S
|
Pharmaceutical substances and preparations for the treatment of oncological diseases and disorders |
|
|
G/S
|
Pharmaceutical substances and preparations for the treatment of oncological diseases and disorders. |
|
|
G/S
|
pharmaceutical substances and preparations for the treatment of oncological diseases and disorders |
|
|
Invention
|
Treating spondyloarthritic conditions with upadacitinib.
Provided are methods for treating vario... |
|
|
Invention
|
Degrader compounds and uses thereof.
Provided herein are compounds, compositions, and methods us... |
|
|
G/S
|
Education services, namely, conducting classes, workshops, training seminars, and in-person discu... |
|
|
G/S
|
Education services, namely conducting classes, workshops, training seminars, and discussion forum... |
|
2021
|
Invention
|
Modulators of the integrated stress pathway.
Provided herein are compounds, compositions, and me... |
|
|
Invention
|
Carrying vest |
|
|
G/S
|
medical services; providing medical information; providing healthcare information to nurse practi... |
|
|
G/S
|
Administration of a discount program for medical patients featuring product savings programs, pro... |
|
2020
|
G/S
|
Charitable services, namely, patient assistance program to provide drugs free of charge to low-in... |
|
|
Invention
|
Protein tyrosine phosphatase degraders and methods of use thereof.
Provided herein are compounds... |
|
|
G/S
|
Pharmaceutical preparations and substances for the treatment of viral, namely herpes, hepatitis, ... |
|
|
G/S
|
pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musc... |
|
|
G/S
|
Pharmaceutical drug mail order services; pharmaceutical services, namely, processing online presc... |
|
|
G/S
|
mail order and online retail pharmacy services; pharmaceutical services, namely, processing of on... |
|
|
G/S
|
Providing medical information to patients and medical professionals in the form of reports in the... |
|
|
G/S
|
Printed matter, namely, pamphlets, brochures, newsletters, handouts, magazines, annual reports, b... |
|
2019
|
G/S
|
pharmaceutical preparations for the treatment of hepatitis C |
|
|
G/S
|
Providing medical information, namely, information regarding medical conditions, treatments and p... |
|
|
G/S
|
Educational services, namely, providing patients with certain medical conditions to speak at educ... |
|
|
G/S
|
Printed materials, namely, advertising and promotional materials in the nature of informational p... |
|
|
G/S
|
Pharmaceutical preparations, namely, antivirals |
|
2016
|
Invention
|
Processes for the preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)... |
